TENAX THERAPEUTICS, INC. (42) | Intellectual Property (2)
- Amendment to the License Agreement of September 20, 2013 by and between Tenax Therapeutics, Inc. and Orion Corporation, dated as of January 25, 2022 (Filed With SEC on January 28, 2022)
- Amendment to License Agreement, dated as of October 9, 2020, by and between Tenax Therapeutics, Inc. and Orion Corporation (Filed With SEC on October 15, 2020)
